Administrative rule changes from the South Dakota Board of Medical and Osteopathic Examiners (BMOE) establishing standards for prescribing controlled substances for chronic, non-cancer pain and other issues will take effect on Oct. 20.
The board established standards for prescribing controlled substances for chronic, non-cancer pain out of work done through an ad hoc committee. The committee met several times and relied on the Federation of State Medical Boards Model of Policy for the Use of Opioid Analgesics in the Treatment of Chronic Pain, the Federation of State Medical Boards Model Policy on Data 2000 and Treatment of Opioid Addition in the Medical Office.
The board also approved the ability to use electronic communication to satisfy the direct personal contact requirement that was previously a part of the collaborative agreement.
More information can be found here.
